OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Formulation and Delivery Technologies for mRNA Vaccines
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Chunxi Zeng, Chengxiang Zhang, Patrick Walker, et al.
Current topics in microbiology and immunology (2020), pp. 71-110
Open Access | Times Cited: 179
Showing 26-50 of 179 citing articles:
The Delivery of mRNA Vaccines for Therapeutics
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Life (2022) Vol. 12, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 54
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Life (2022) Vol. 12, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 54
An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, et al.
Biomaterials (2022) Vol. 286, pp. 121570-121570
Open Access | Times Cited: 53
Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, et al.
Biomaterials (2022) Vol. 286, pp. 121570-121570
Open Access | Times Cited: 53
Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects
Justus E. Hallam, Tyanez Jones, Jessica Alley, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 1-10
Open Access | Times Cited: 52
Justus E. Hallam, Tyanez Jones, Jessica Alley, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 1-10
Open Access | Times Cited: 52
Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, et al.
Bioactive Materials (2022) Vol. 22, pp. 491-517
Open Access | Times Cited: 51
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, et al.
Bioactive Materials (2022) Vol. 22, pp. 491-517
Open Access | Times Cited: 51
Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
Lijuan Duan, Qian Wang, Cuilian Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Lijuan Duan, Qian Wang, Cuilian Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells
Marco Künzli, Stephen O’Flanagan, Madeleine LaRue, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 50
Marco Künzli, Stephen O’Flanagan, Madeleine LaRue, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 50
Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
Sodiq Ayobami Hameed, Stéphane Paul, Giann Kerwin Y. Dellosa, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Sodiq Ayobami Hameed, Stéphane Paul, Giann Kerwin Y. Dellosa, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1127-1127
Open Access | Times Cited: 42
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1127-1127
Open Access | Times Cited: 42
Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review
Soren Nooraei, Alireza Sarkar Lotfabadi, Milad Akbarzadehmoallemkolaei, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 453-453
Open Access | Times Cited: 40
Soren Nooraei, Alireza Sarkar Lotfabadi, Milad Akbarzadehmoallemkolaei, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 453-453
Open Access | Times Cited: 40
Lipid nanoparticle-mediated mRNA delivery in lung fibrosis
Matteo Massaro, Suhong Wu, Gherardo Baudo, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 183, pp. 106370-106370
Open Access | Times Cited: 30
Matteo Massaro, Suhong Wu, Gherardo Baudo, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 183, pp. 106370-106370
Open Access | Times Cited: 30
Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA
Hao Miao, Ke Huang, Yingwen Li, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123050-123050
Closed Access | Times Cited: 29
Hao Miao, Ke Huang, Yingwen Li, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 123050-123050
Closed Access | Times Cited: 29
An Overview of the Use of Nanoparticles in Vaccine Development
Daniel Lozano, Vicente Larraga, María Vallet‐Regí, et al.
Nanomaterials (2023) Vol. 13, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 28
Daniel Lozano, Vicente Larraga, María Vallet‐Regí, et al.
Nanomaterials (2023) Vol. 13, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 28
All‐Trans‐Retinoic Acid‐Adjuvanted mRNA Vaccine Induces Mucosal Anti‐Tumor Immune Responses for Treating Colorectal Cancer
Wei Li, Yijia Li, Jingjiao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 10
Wei Li, Yijia Li, Jingjiao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 10
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Srdan Tadic, Alfredo Martı́nez
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 9
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 9
Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics
Laurine Hourdel, Noureddine Lebaz, Florent Peral, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125297-125297
Closed Access | Times Cited: 1
Laurine Hourdel, Noureddine Lebaz, Florent Peral, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125297-125297
Closed Access | Times Cited: 1
Internal cap-initiated translation for efficient protein production from circular mRNA
Keisuke Fukuchi, Yuko Nakashima, Naoko Abe, et al.
Nature Biotechnology (2025)
Closed Access | Times Cited: 1
Keisuke Fukuchi, Yuko Nakashima, Naoko Abe, et al.
Nature Biotechnology (2025)
Closed Access | Times Cited: 1
Perspectives on RNA Vaccine Candidates for COVID-19
Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 56
Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder, et al.
Advanced NanoBiomed Research (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 52
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder, et al.
Advanced NanoBiomed Research (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 52
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Elisa Danese, Martina Montagnana, Gian Luca Salvagno, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 9, pp. 1585-1591
Open Access | Times Cited: 52
Elisa Danese, Martina Montagnana, Gian Luca Salvagno, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 9, pp. 1585-1591
Open Access | Times Cited: 52
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?
Rossella Talotta, Erle S. Robertson
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 52-60
Open Access | Times Cited: 46
Rossella Talotta, Erle S. Robertson
Cytokine & Growth Factor Reviews (2021) Vol. 60, pp. 52-60
Open Access | Times Cited: 46
Profiles of current COVID-19 vaccines
Franz X. Heinz, Karin Stiasny
Wiener klinische Wochenschrift (2021) Vol. 133, Iss. 7-8, pp. 271-283
Open Access | Times Cited: 43
Franz X. Heinz, Karin Stiasny
Wiener klinische Wochenschrift (2021) Vol. 133, Iss. 7-8, pp. 271-283
Open Access | Times Cited: 43
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 37
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 37
Optimization of Lipid Nanoformulations for Effective mRNA Delivery
Huiling Chen, Xuan Ren, Xu Shi, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2893-2905
Open Access | Times Cited: 32
Huiling Chen, Xuan Ren, Xu Shi, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2893-2905
Open Access | Times Cited: 32
Next generation self-replicating RNA vectors for vaccines and immunotherapies
Parinaz Aliahmad, Shigeki J. Miyake-Stoner, Andrew J. Geall, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 6, pp. 785-793
Open Access | Times Cited: 29
Parinaz Aliahmad, Shigeki J. Miyake-Stoner, Andrew J. Geall, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 6, pp. 785-793
Open Access | Times Cited: 29
